Covid-19 vaccines are poised to become big business. Its potential to generate staggering revenue has already added billions of dollars to the market value of drug makers like Pfizer and Moderna.. That promise is also drawing scrutiny in Washington. Rising prescription drug costs are one of the few problems where …
Read More »Berkshire Hathaway Inc. Cl A shares outperform the competition on a good trading day
Shares of Berkshire Hathaway Inc. Cl A BRK.A, + 0.75% It rose 0.75% higher to $ 291,621.00 on Friday, in what turned out to be a poor trading session for the stock market, with the S&P 500 Index SPX, -0.61% falling 0.62% to 3,215.63 and DIA Jones Industrial Average DJIA, …
Read More »Berkshire Hathaway Inc. Cl A shares outperform the competition on a good trading day
Shares of Berkshire Hathaway Inc. Cl A BRK.A, + 0.75% It rose 0.75% higher to $ 291,621.00 on Friday, in what turned out to be a poor trading session for the stock market, with the S&P 500 Index SPX, -0.61% falling 0.62% to 3,215.63 and DIA Jones Industrial Average DJIA, …
Read More »Can the Fed tame an avalanche of corporate distress? Bond investors are betting on it
The Federal Reserve has shown that it knows how to maintain the flow of credit during a crisis. But bond investors now also expect the Fed’s unprecedented stimulus in financial markets to change the course of the credit cycle – that is, preventing more companies from falling than expected just …
Read More »Moderna lost a patent case and stock is slipping
Text size Maddie Meyer / Getty Images Moderna on Thursday lost a patent case that had been almost entirely overlooked as the stock increased due to excitement over the company’s Covid-19 vaccine, which will be tested in a large Phase 3 trial to begin. next week. What the decision issued …
Read More »